Diagnostic Kits/Paper: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
* chemical patents at turn of century (see Palombi's work) | * chemical patents at turn of century (see Palombi's work) | ||
=== Overview of IP Landscape === | |||
==== When IP Does and Does Not Work Effectively ==== | ==== When IP Does and Does Not Work Effectively ==== | ||
Revision as of 12:36, 3 December 2009
Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell
Last Draft: December 3, 2009
Introduction
Description of the GDx Market
Defining Genetic Diagnostics
Brief History of GDx and Related Technology
- chemical patents at turn of century (see Palombi's work)
Overview of IP Landscape
When IP Does and Does Not Work Effectively
Our Research Questions
Our Methodology
Forces affecting the GDx Industry
- Technical advances